×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by SCHIMMEL PAUL

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ATYRaTYR PHARMA INCSCHIMMEL PAULDirectorJul 22, 2024Buy$1.7441,05271,500354,075Jul 24, 2024, 05:29 PM
ATYRaTYR PHARMA INCSCHIMMEL PAULDirectorJul 23, 2024Buy$1.826,64812,075360,723Jul 24, 2024, 05:29 PM
ATYRaTYR PHARMA INCSCHIMMEL PAULDirectorJul 24, 2024Buy$1.9352,300101,038413,023Jul 24, 2024, 05:29 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorMay 10, 2023Buy$2.25200,000450,000313,023May 11, 2023, 09:00 AM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorSep 20, 2021Buy$8.00250,0002,000,000252,890Sep 22, 2021, 08:19 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorMay 18, 2021Buy$3.9850,000199,000113,023May 20, 2021, 08:55 AM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorMay 20, 2020Sale$3.648,44730,739429,143May 22, 2020, 08:13 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorFeb 10, 2020Buy$4.25254,0001,079,500437,590Feb 11, 2020, 11:58 AM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 12, 2019Option Exercise$0.541,848,4281,000,0002,570,242Apr 16, 2019, 04:31 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorNov 26, 2018Buy$0.54147,22579,796882,302Nov 28, 2018, 07:12 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorAug 31, 2018Buy$0.7222,00015,752714,328Sep 05, 2018, 04:04 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorSep 04, 2018Buy$0.7620,74915,709735,077Sep 05, 2018, 04:04 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorAug 30, 2018Buy$0.7689,27567,483692,328Aug 31, 2018, 04:11 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorAug 29, 2018Buy$0.7275,13654,090603,053Aug 31, 2018, 04:11 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorMay 18, 2018Buy$1.00150,000149,445527,917May 21, 2018, 06:50 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorMar 13, 2018Option Exercise$49.2427,8231,369,92727,823Mar 14, 2018, 07:39 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorMar 13, 2018Sale$150.0027,8234,173,4500Mar 14, 2018, 07:39 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorAug 31, 2017Buy$2.6594,336249,990377,917Sep 05, 2017, 08:22 PM
TOCATocagen IncSCHIMMEL PAULDirectorApr 19, 2017Buy$10.0010,000100,00013,623Apr 21, 2017, 05:34 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorDec 20, 2016Buy$2.2715,00034,110711,814Dec 22, 2016, 11:53 AM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorDec 21, 2016Buy$2.2810,00022,818721,814Dec 22, 2016, 11:53 AM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorDec 15, 2016Buy$2.5040,00099,912686,814Dec 19, 2016, 07:41 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorDec 16, 2016Buy$2.4010,00023,973696,814Dec 19, 2016, 07:41 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 14, 2016Buy$4.2233,619141,859283,581Apr 15, 2016, 05:46 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 14, 2016Buy$4.1432,600135,07553,012Apr 15, 2016, 05:46 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 13, 2016Buy$3.859,83537,865249,962Apr 14, 2016, 07:20 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 12, 2016Buy$3.752,5819,68220,412Apr 13, 2016, 06:34 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 12, 2016Buy$3.706,54624,220240,127Apr 13, 2016, 06:34 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 11, 2016Buy$3.5627,40097,643233,581Apr 13, 2016, 06:32 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 11, 2016Buy$3.595,25918,89117,831Apr 13, 2016, 06:32 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 11, 2016Buy$3.5732,659116,535220,231Apr 12, 2016, 03:57 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 08, 2016Buy$3.2285,000273,649187,572Apr 11, 2016, 12:39 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 07, 2016Buy$3.1940,000127,584102,572Apr 08, 2016, 12:19 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 06, 2016Buy$3.2025,00080,00062,572Apr 07, 2016, 03:40 PM
LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorApr 05, 2016Buy$3.5225,00088,11737,572Apr 06, 2016, 07:19 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorApr 21, 2015Option Exercise$28.6910,000286,85010,000Apr 23, 2015, 04:43 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorApr 21, 2015Sale$130.0210,0001,300,2000Apr 23, 2015, 04:43 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorMar 17, 2015Sale$120.00947113,6400Mar 19, 2015, 06:49 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorMar 19, 2015Option Exercise$27.289,053246,9669,053Mar 19, 2015, 06:49 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorMar 19, 2015Sale$120.009,0531,086,3600Mar 19, 2015, 06:49 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorMar 17, 2015Option Exercise$27.2894725,834947Mar 19, 2015, 06:49 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorDec 08, 2014Option Exercise$22.0915,000331,35015,000Dec 10, 2014, 04:39 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorDec 08, 2014Sale$105.0015,0001,575,0000Dec 10, 2014, 04:39 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorOct 28, 2014Option Exercise$15.9115,000238,65015,000Oct 30, 2014, 05:03 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorOct 28, 2014Sale$95.0015,0001,425,0000Oct 30, 2014, 05:03 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorJan 13, 2014Option Exercise$15.8215,000237,30015,000Jan 14, 2014, 05:20 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorJan 13, 2014Sale$85.3615,0001,280,4000Jan 14, 2014, 05:20 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorDec 20, 2013Option Exercise$11.3315,000169,95015,000Dec 23, 2013, 04:56 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorDec 20, 2013Sale$65.0015,000975,0000Dec 23, 2013, 04:56 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorOct 22, 2013Sale$60.0015,000900,000126,216Oct 24, 2013, 05:23 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorOct 22, 2013Option Exercise$9.3015,000139,500141,216Oct 24, 2013, 05:23 PM
ALNYALNYLAM PHARMACEUTICALS, INC.SCHIMMEL PAULDirectorFeb 21, 2012Buy$10.7593,023999,997252,111Feb 23, 2012, 05:11 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe